Saturday, October 6, 2018: 2:00 PM-3:15 PM
Room: W 2006-2008
At the conclusion of this session, participants will be able to:
- evaluate the current status of community-acquired and healthcare-acquired gram-positive bacterial infections in children and why these infections continue to be a threat to pediatric patients.
- describe the evolution of resistance in gram-negative bacteria and how this emergence of multi-drug resistance is impacting children.
- discuss the potential niches of newer antibiotic agents with enhanced gram-negative activity.
Academicians, Clinicians, Epidemiologists, Fellows, Healthcare workers, Hospital epidemiologists, Infection preventionists, Infectious diseases pediatricians, Infectious diseases physicians, Investigators, Lab personnel, Medical students and residents, Members-in-training, Microbiologists, Pharmacists, Public health practitioners, Researchers, Scientists
Trainee, Pediatric ID
Latania K. Logan, MD, MSc, Rush University Medical Center
Pranita Tamma, MD, MHS, Johns Hopkins University School of Medicine
Maximum of 1.25 hours of AMA PRA Category 1 Credit™
ACPE 1.25 knowledge-based contact hours of pharmacy CE
L. K. Logan,